Title | Description |
|---|---|
| Trial ID | KF7039-01 |
| Compound | RTX-GRT7039 |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis |
| Indication | Osteoarthritis |
| UTN | U1111-1268-7314 |
| CTG ID | NCT05248386 |
| CTIS ID (former EudraCT) | 2021-005029-26 |
| Trial status | Completed |
| FPI | August 26, 2022 |
| LPO | November 18, 2024 |
| Countries | Canada, Czechia, France, Germany, Italy, Japan, Mexico, Netherlands, Poland |
| Gender | All |
| Age | >= 18 years of age |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.